Accessing Epidemiology Data Just Got Easier: Introducing GIDEON R for Researchers

Screenshot of the GIDEON R package in use

GIDEON R package in use

GIDEON API R wrapper package (in beta) brings all the benefits of R to epidemiological research. Access GIDEON infectious diseases database with minimal coding.

We want researchers to focus on what they do best – using epidemiology to help the world understand and prepare for infectious disease outbreaks”

— Uri Blackman

LOS ANGELES, CALIFORNIA, UNITED STATES, August 3, 2021 /EINPresswire.com/ — GIDEON Informatics, the Global Infectious Diseases and Epidemiology Online Network, announced their new GIDEON API R wrapper package in beta. GIDEON R offers researchers the power to analyze data from the GIDEON infectious diseases database without programming REST API queries.

GIDEON is one of the most well-known references for infectious diseases and their global occurrences since the 1900s. The database is updated daily with information on 25,000+ ongoing and historical infectious disease outbreaks, granular disease-specific maps, detailed tracking of zoonotic diseases across countries, and insights on over 360 infectious diseases, 2000+ pathogens, and 30,000 drugs and vaccines. Also featured are 23,600 country-specific notes with over three million words of text that outline the status of specific infections within each country.

“We want researchers to focus on what they do best – using epidemiology to help the world understand and prepare for infectious disease outbreaks,” says Uri Blackman, CEO at GIDEON Informatics. “In just the past three years, almost 200 scientific studies that used GIDEON data were published. Now with GIDEON R, many more researchers can access valuable infectious disease data with minimal coding.”

Researchers who already tried the beta version of the GIDEON R package found it extremely efficient.

“I am experimenting with the new R wrapper and I just love it,” said Dr. Nermin Ghith, a Post-doctoral researcher at the Technical University of Denmark.

The COVID-19 pandemic put a huge spotlight on the importance of analyzing data on infectious disease outbreaks in real-time. With the popularity and ease of global travel, a pathogen can spread to all corners of the globe in just a weekend. Infectious disease specialists, public health officials, and frontline clinicians are under greater pressure to increase vigilance for emerging infectious diseases. GIDEON R empowers faster access to the historical and current outbreak and infectious disease data.

The GIDEON R package brings simplicity, convenience, flexibility, and reproducibility to the world of epidemiological research. Research teams can get straight to the analytics using the GIDEON database. There is no need for advanced programming skills or wasted time testing and sequencing API calls, validating parameters, and fixing other issues before they start.

Using GIDEON R, researchers can create scripts and simulate all data analysis steps. This way, scientists can perform different runs without worrying about changes to the process. Additionally, using R, researchers can create any type of graph or chart, simple or advanced. GIDEON R also facilitates global collaboration. It is compatible with any platform – it does not matter if you use Windows, Mac, or another system.

R is a free, open-source programming language that is rapidly gaining popularity in the field of research. It is already a regular fixture in standard data analytics university programs. Public Health agencies and epidemiological researchers are increasingly using R for their studies and reports.

The GIDEON R package is available today for researchers, infectious disease specialists, public health officials, medical librarians, and more.
For more information, contact info@gideononline.com

About GIDEON Informatics:

GIDEON Informatics exists to advance the global effort against Infectious Disease. The company was founded in 1992 and produces the GIDEON web application and an ebook series for health professionals and educators.

GIDEON toolkit helps protect society by providing reliable, timely epidemiological data. The application saves doctors precious time in diagnosing and treating infectious diseases and provides state-of-the-art tools to train the healthcare workers of tomorrow.

Hundreds of customers from around the world, including educational institutions, hospitals, public health departments, and microbiology laboratories, have chosen GIDEON as their diagnosis-and-reference tool for Infectious Diseases and Microbiology. GIDEON Informatics is managed by an experienced executive team and maintains a distinguished medical advisory board.

Kristina Symes
GIDEON Informatics
kristina@gideononline.com


Source: EIN Presswire

CCHR Says the Olympics Raise Mental Health Concerns but not Treatment Harms

CCHR Says the Olympics Raise Mental Health Concerns but not Treatment Harms

The Tokyo Olympics has shown importance of athletes’ mental health, but this shouldn’t be equated with “mental illness” that can lead to forced and damaging treatment with psychotropics, electroshock and other brain interventions.

The Tokyo Olympics has shown importance of athletes’ mental health but shouldn’t be equated with “mental illness” that can lead to forced and damaging treatment

LOS ANGELES, CALIFORNIA, UNITED STATES, August 3, 2021 /EINPresswire.com/ — The Citizens Commission on Human Rights International (CCHR) says that the Olympic Games in Tokyo has raised the importance of mental health issues but says there needs to be a clear distinction between this and mental “illness” treatment today. For decades, psychiatrists have re-defined mental health as “mental disorder” or “illness,” which has stigmatized individuals and led them onto a path of physically damaging treatment that can harm them, but not cures.

CCHR says that because of this, a psychiatric apartheid has occurred, where mental health policy or practice has separated and segregated groups deemed to be mentally ill and discriminated against them with forced hospitalization and treatment, which can be brutal. Jan Eastgate, president of CCHR International says “It can ruin mental health, rather than improve it.”

“The Olympics has brought to light the stresses of athletes competing, their grueling training routines and being under constant public pressure and expectations to win ‘gold.’ It stands to reason that having a solid mental health outlook is a vital part of such challenges but that this can also falter. CCHR applauds all the athletes for not just their dedication and courage but also their service to sport and their respective countries,” Eastgate states.

However, she points out that for more than 50 years, CCHR has exposed and continues to expose rampant psychiatric abuse and treatments that harm mental health. The group’s Mental Health Declaration of Human Rights, written in 1969, lays out 30 points that, if largely implemented by governments and health departments across the globe, could, prevent such abuse from occurring and so enable people to achieve true mental health—a positive outlook both emotionally and in thoughts and actions that enables a better life, not hampered by physically damaging “treatments.”

CCHR points out that psychiatrists diagnose by using descriptive names based on biased observation to redefine not doing well mentally as a physical disease—with not a single medical or scientific test to confirm this. Post WWII, they used the term “mental hygiene” which became synonymous with eugenics and euthanasia and changed the term to avoid negative connotations. Today, it is broadly called “mental health,” but it is important to differentiate between this and psychiatry’s definition of “mental disorder.” The two should not be confused, CCHR says, to avoid being trapped into thinking that a mind-altering drug or electroshock is a medical solution.

In medicine, strict criteria exist for calling a condition a disease: a predictable group of symptoms and the cause of the symptoms or an understanding of their physiology (function) must be proven and established. Chills and fever are symptoms. Harvard Medical School psychiatrist Joseph Glenmullen says that in psychiatry, “all of its diagnoses are merely syndromes [or disorders], clusters of symptoms presumed to be related, not diseases.” Dr. Darshak Sanghavi, clinical fellow at Harvard Medical School also wrote that “there is no blood test or brain scan for major depression. No geneticist can diagnose schizophrenia.”[1]

Although the brain is part of the nervous system, which receives and sends impulses into the body’s system, there’s no scientific proof that mental health thinking physically resides in the brain. But psychiatric drugs and electroshock impact brain function.

The psychotropic drugs prescribed to athletes tend to favor those that are “energizing” and less likely to commonly cause sedation, weight gain, cardiac side effects, and tremor. Side effects may be debilitating for the athlete because of potential performance impairment. Even “energizing” drugs such as antidepressants can cause tiredness, dizziness, weight gain, anxiety, aggression, unusual changes in behavior or mood.[2] Psychostimulants adverse effects include angina, blood pressure changes, blurred vision, depression, insomnia, suicidal thoughts, nervousness, seizures and even psychosis.[3]

These “work” by influencing the normal functions of the body: they speed up or slow them down or overwhelm them. They “mask” mental problems. Meanwhile, they tend to wear out your body. Like a car run on rocket fuel, a person may be able to get it to run a thousand miles an hour to the end of the block, but the tires, the engine and the internal parts fly apart in doing so. “What ends up happening,” wrote Dr. Beth McDougall, a health center medical director, “is that someone feels good for a while and then very often they have to have their dose increased. And then they feel good for a while and then they might have to have it increased again, or maybe they’ll switch agents.” But, “you’re not actually getting to the root of what’s going on.”[4]

CCHR warns that legitimate informed consent does not exist in the mental health system when it fails to inform those needing help that a mental disorder diagnosis is not based on scientific tests and, therefore, any treatment ensuing from this, constitutes “torture or cruel, inhuman or degrading treatment.” According to United Nations agencies and the World Health Organization, forced treatment amounts to torture.

A UN Special Rapporteur on health, Dr. Danius Puras said: “There is now unequivocal evidence of the failures of a system that relies too heavily on the biomedical model,” including psychotropic drugs.[5]

Eastgate sums up: “It is important for people to know the differences between mental health and psychiatric ‘disease,’ and to be informed of the failures of the psychiatric profession in ensuring mental health is actually achieved.”

CCHR has been responsible for more than 190 laws that have enacted protections based on its Mental Health Declaration of Human Rights and urges individuals seeking help to review this and what should be their inalienable rights when choosing how to get mental health help. See also CCHR’s Psychiatric Drugs Side Effects Search Engine.

[1] “Prozac Backlash by Joseph Glenmullen, M.D.,” http://www.webheights.net/depression/glenm/pb.htm; Dr. Darshak Sanghavi, “Health Care System Leaves Mentally Ill Children Behind,” The Boston Globe, 27 Apr. 2004, http://www.darshaksanghavi.com/columns/mentally%20ill.htm

[2] Rachel Reiff Ellis, “What Are the Side Effects of Antidepressants?” WebMD, 5 Sept. 2019, https://www.webmd.com/depression/side-effects-antidepressants

[3] Psychostimulants: The fact about the effects, CCHR International, https://www.cchr.org/sites/default/files/education/psychostim-booklet.pdf

[4] Ibid.

[5] https://www.cchrint.org/2021/06/07/un-special-rapporteur-dainius-puras-addresses-psychiatrys-global-coercion-crisis/, citing: “World needs ‘revolution’ in mental health care – UN rights expert,” 2017, http://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=21689&LangID=E#sthash.MMIxDbIx.dpuf

Amber Rauscher
Citizens Commission on Human Rights
2137983761 ext.
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

eCare21 Announces Integration Compatibility with PointClickCare Platform

Partnership improves transition of patient care for providers within Long-Term and Post-Acute Care communities.

Our transitions of care management program utilizes eCare21 to provide seamless, comprehensive, patient centered team-based transitions of care and chronic care management.”

— Dr. Amina Ahmed, MD, CareOne, CMO

TAMPA, FL, U.S., August 3, 2021 /EINPresswire.com/ — eCare21, Inc. (www.ecare21.com), the industry leader in virtual care is pleased to announce that it has recently become a PointClickCare Marketplace Partner. Through its Marketplace and Marketplace Partners, PointClickCare, the leading cloud-based software vendor for the senior care market, offers the LTPAC market’s largest ecosystem of integrated software and service solutions. “Our partnership with eCare21, and other Marketplace partners, is further testament to our continually growing partner network and ecosystem, and the wealth of possibilities it provides our customers to extend their technology capabilities.” says Chris Beekman, Marketplace Director, PointClickCare.

eCare21 technology provides a comprehensive end-to-end patient care solution to providers across the healthcare ecosystem to better manage chronic conditions remotely, improve care decision making, and reduce hospitalizations.

Through this Marketplace partnership, eCare21 has completed an integration with the PointClickCare platform that will enable care providers using their solution to optimize their technology solutions to deliver seamless transitions of patient data within the Long-Term and Post-Acute Care (LTPAC) community. eCare21 provides a secure, cloud-based virtual care solution that improves communications among healthcare organizations, patients, and caregivers by integrating remote patient monitoring, chronic care management, medication adherence, telehealth, and billing into Electronic Health Records (EHR) and other systems to create a single comprehensive patient view that enables better information sharing, better decision making, and better outcomes.

By utilizing a FHIR integration solution developed in partnership with CYBX (www.cyberionix.com), eCare21 ensures continuous compliance with ONC interoperability requirements.

eCare21 bridges the technology and data gaps that are found within healthcare systems, leading to better patient management, reduced costs, and improved outcomes. By providing a single, comprehensive solution that seamlessly integrates with EHRs and other data sources, eCare21 empowers clinicians to make better decisions based on a complete patient record.

This comprehensive perspective enables provider organizations to achieve:
– Increased physician, patient, and caregiver collaboration
– Improved health outcomes, lower costs, and reduced risk
– Increased transparency of patient information for patient and extended care team
– Increased visibility and functionality at all points of chronic care management

eCare21’s Patient Engagement Center (PEC) provides a clinically staffed patient and care management resource that supports patient on-boarding, monitoring, care management, and escalation to providers based on individualized workflows. This process provides efficient use of provider clinical resources, enabling them to practice at the top of their license.

"eCare21’s ability to integrate into the PointClickCare platform contributes to creating robust longitudinal patient medical records. eCare21 is the first virtual care solution we have used that bridges the vital data gaps which occur during patient transitions, " says Dr. Amina Ahmed, MD, (CMO, CareOne). "eCare 21’s connectivity with RPM technology further enhances the provider’s ability to virtually monitor patients in real-time. Our transitions of care management program utilizes eCare21 to provide seamless, comprehensive, patient centered team-based transitions of care and chronic care management. eCare21 is CareOne’s choice for delivering the right care, right time and right place."

The PointClickCare Marketplace is a network of authorized third-party technology partners that enable customers to easily evaluate solutions provided by its extended network. The Marketplace is the industry’s most complete ecosystem of LTPAC solutions for companies and solutions in senior care that complement and integrate with the PointClickCare platform.

About eCare21
Better care starts with better information and better communication among providers, patients, and caregivers. eCare21’s Virtual Care Platform bridges existing data and care gaps with a single solution that ties together EHRs, remote patient monitoring, chronic care management, virtual visits, and more, giving clinicians a complete record of patient data to make better decisions, leading to better outcomes.

For more information on how eCare21’s end to end virtual care solution improves efficiency and communication for clinicians, health systems, payers, patients, and more, please contact us at info@ecare21.com or visit our website at www.eCare21.com

About PointClickCare
With a suite of fully-integrated applications powered by cloud-based healthcare software, PointClickCare leads the way in helping care providers connect, collaborate, and share data within their network. PointClickCare provides diverse care teams across the care continuum real-time patient insights at any stage of a patient’s healthcare journey, enabling better decision making and improved clinical outcomes at lower cost. Over 21,000 long-term and acute/post-acute care providers, and over 1,300 hospitals, use PointClickCare today. For more information on PointClickCare’s software solutions, visit pointclickcare.com.

Contact:

eCare21, Inc.
Vadim Cherdak
CEO and Founder
vcherdak@ecare21.com

PointClickCare Technologies
Jennifer McCrindle
Media and Public Relations Manager
Jennifer.McCrindle@pointclickcare.com

Marketing Dept.
eCare21, Inc.
+1 888-970-4628
info@ecare21.com


Source: EIN Presswire

Oxygen Plant with 283 LPM capacity inaugurated at Maharaja Agrasen Hospital in Bangalore

Oxygen Plant Ribbon cutting at Maharaja Agrasen Hospital in Bangalore

Oxygen Plant Ribbon cutting at Maharaja Agrasen Hospital in Bangalore

Oxygen Plant at Maharaja Agrasen Hospital in Bangalore

Oxygen Plant at Maharaja Agrasen Hospital in Bangalore

As the fight against the Covid-19 continues, the collaboration of the social welfare and private sector to augment the medical infrastructure will further accelerate the relief efforts.”

— Dr Satish Jain

BANGALORE, KARNATAKA, INDIA, August 3, 2021 /EINPresswire.com/ — A much-needed oxygen plant has been installed in Maharaja Agrasen Hospital, Padmanabhanagar in Bangalore this Tuesday.

Ms.Deeksha Dinesh, Trustee of Ashraya Hastha Trust along with Dr Satish Jain President of Maharaja Agrasen Hospital on Tuesday 3rd August 2021 inaugurated medical oxygen plant set up at the Maharaja Agrasen Hospital, Padmanabhanagar in Bangalore primarily funded by AHT Trust.

The Oxygen Plant will generate 283 liters per minute for supplying oxygen to the patients of the hospital and provides help to the healthcare facilities to manage peak consumption flows.

Dr Satish Jain – President of Maharaja Agrasen Hospital said “As the fight against the Covid-19 continues, the collaboration of the social welfare and private sector to augment the medical infrastructure will further accelerate the relief efforts. Private companies and trusts such as AHT trust have been supporting various organizations for Covid relief. This medical oxygen plant is the need of the hour in present situation” Satish Jain said in his address after the inauguration.

"With the installation of oxygen generation plants at most hospitals, the load on vendors supplying liquid medical oxygen will reduce and these will be able to cater to smaller hospitals," he said.

The hospitals in Bangalore struggled immensely during the second wave of the pandemic to keep the oxygen supply going. Cylinders had to be sent to oxygen plants to be filled and it could take well over 24 hours due to the queues being long.

“A stitch in time saves nine. Similarly, oxygen is vital for all living beings. AHT in these challenging times believes Life saved today could save many more in future with no expectations! In these tough times all of us are trying the best we can to survive and get through it. We as trustees only want to be able to help aid that for those who don't have the resources. We believe in working towards making a better world than what we live in. Equal opportunities to everyone” as said by Ms.Deeksha Dinesh from AHT.

Amid a possible third wave of Covid-19, Maharaja Agrasen Hospital was keen on installing their own oxygen generation plant to avoid a repeat of the oxygen crisis Bengaluru witnessed during the second wave. This plant will ensure a sustained supply of oxygen for all 80 oxygenated and ICU beds reserved for the Covid-19 ward.

On this occasion Raj Kumar Kandoi, Rajender Goel, Satish Jain, R.K.Poddar, Krishan Agarwal felicitated and honored Ms.Deeksha Dinesh for their contribution and support. Dr.Abhishek Modi, Dr.GopiKrishna, Dr.Kumar, Trustee Kamal Agarwal and administrator Pooja Guruprasad along with staff were present at the ceremony.

“A stitch in time saves nine. Similarly, oxygen is vital for all living beings. AHT in these challenging times believes Life saved today could save many more in future with no expectations! In these tough times all of us are trying the best we can to survive and get through it. We as trustees only want to be able to help aid that for those who don't have the resources. We believe in working towards making a better world than what we live in. Equal opportunities to everyone” as said by Ms.Deeksha Dinesh from Ashraya Hastha Trust.

Seema Sharma
Osxem Digital Marketing Agency and Consultants
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

The LightBoard Depot Inc. launches the Mini

The LightBoard Depot Inc. launches the Mini Version

Do more at your desk or go mobile with innovative, remote teaching technology .

People are investing in our products over laptops because The LightBoard Depot Inc. has a positive impact on learners in a remote environment.”

— Christopher Cavalieri, The LightBoard Depot Inc.

NEW YORK CITY, UNITED STATES, August 3, 2021 /EINPresswire.com/ — They say bigger is better, but smaller is sometimes just right in a big world.

You see, The LightBoard Depot Inc. just unveiled its new Mini version, which will benefit scores of professionals in an array of industries, including Teaching & Education, Telehealth & Medicine, Real Estate, Banking and Finance, Coaching & Training, Design & Consulting, Performance & Arts, Manufacturing, and more.

The LightBoard Depot Inc. launched their technology on the market at the height of the pandemic and now they have come out with a new product that will offer even more convenience for educators and professionals.

The LightBoard Depot Inc. is fascinating in its design and application. The LightBoard Depot Inc. utilizes a webcam, tripod, and a piece of glass that allows the user to broadcast to an audience in a conference, seminar, or classroom setting. Showcasing Free Open-Source Software, The LightBoard Depot Inc. user can write, draw, and explain with ease as the technology flips the words around so an audience can understand. The technology also allows users to present videos, images, power-points and other documents.

The Mini is 24×36 in size and will fit on just about any desk and is easy to pack-up and take with you for road trips and business trips. Even better, while the Mini is more compact, and easy to move around, it is also more affordable compared to the standard LightBoard version that was launched last fall. Both are ideal for teaching and coaching, however, the Mini will be a huge seller as we enter a ‘new normal.’

“People are raving about our standard LightBoard, but we learned first-hand that users also desired a smaller version, one that fits on their desks, and one they can pack-up and travel with,” explains Christopher Cavalieri, who is the Director of The LightBoard Depot Inc.

“So, we are giving the consumers what they want – a smaller version of the LightBoard that is more compact, mobile, and convenient for different settings, like a home office, a business office, a hotel room, or even boardroom.”

The LightBoard Depot Inc. Mini retails at around $2,000 (CDN), while the standard version will cost you about $3,000.

Mike Justason, The LightBoard Depot Inc. creator and Assistant Professor in the Faculty of Engineering at McMaster University, says the launch of the Mini scripts a new chapter in remote teaching and learning.

“We created this technology with one goal in mind: to do something to make teaching and learning better for everyone during these unprecedented times,” explains Justason. “I support anyone who wants to make online learning better, because online doesn’t have to suck,” he laughs, “and now the Mini version will offer even more educators and professionals alike with the convenience and efficiency they want when it comes to remote teaching, and even coaching.”

As we enter a ‘new normal,’ the Mini will come in handy as many universities, colleges, schools and businesses will be experimenting with a remote and in-class/in-person hybrid model.

“People who are using our technology find it easy to set-up, easy to use, and they like how it engages their audiences,” says Cavalieri. “We know one thing: our world is now a different place and people are investing in our products over laptops because The LightBoard Depot Inc. has a positive impact on learners in a remote environment. The launch of the Mini is our way of making innovative technology even more accessible to educators and professionals in a post-pandemic world.”

The LightBoard Depot Inc. are partnered with The Forge, an initiative built by McMaster University in Hamilton. The Forge is a business incubator funded by McMaster University, serving novel and scalable start-ups in the Hamilton, Greater Toronto Area and Niagara Regions.

The technology is being used by scores of notable higher-education institutions, businesses and organizations, including McMaster University and Mohawk College in Hamilton, Durham Deaf Services, Conestoga College in Kitchener, The Beanstalk Project, and Arts For A Better Tomorrow in Los Angeles. The LightBoard Depot Inc. is now getting big interest from business leaders and educators in Telemedicine, and corporations involved in commerce, banking, and healthcare.

Paul Fitzgerald
Salt & Pepper Media Inc.
+1 2897956176
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

The LightBoard Depot Inc. launches the Mini version.


Source: EIN Presswire

Things Are Coming Together – GHIC Music

Gods House International Centre Music, Bristol, UK

GHIC Music - Things Are Coming Together

New Release from GHIC Music

Story behind the music

I was also seven months pregnant with my son – which made the song even more applicable to me personally”

— Natalie Ipinyomi

BRISTOL, AVON, UNITED KINGDOM, August 3, 2021 /EINPresswire.com/ — In 2019 I heard the words clearly "Its coming together, bone by bone." Pastor Osien Sibanda, senior Pastor of my church, God's House International Centre (GHIC), had proclaimed. Following this, he (instagram: @osiensibanda) asked the worship team of the church (GHIC Music), to go and write a song and those lyrics seemed to stay with me for a while.

I prayed and asked God to help and a year later, when the leader of the GHIC Music team Temitope Ezobi (instagram: @temitopeezobi), asked us to submit songs for the GHIC Music project, the lyrics and music finally came. I honestly thought that the song would be very wordy and complex, but God had other plans! Goziam Okogwu (instagram: @goz_i_am), our producer also reassured me during our group writing session that the simpler the song, the better. The process in which we put the music, the harmonies and lyrics together was a good one, as we had all hands on deck making it a collective effort. I had a lot of help from Goziam and the team with regards to bringing to life the vision I had musically.

During the recording process, we decided to add another GHIC Music lead vocalist in the person of Sandile Nyandoro (instagram: @sandile_nya) and she did such an amazing job! She added more flavor and charisma to the song. It is worth noting that during the recording process, I was seven months pregnant with my son. This has made the song really special and more applicable to me personally – I knew that it was a timely declaration for all the things I was going through in my life at that point in time.

I really love the simplicity of the song and this is what makes the message more powerful. Its release is also truly relevant to the times we are in with the situation of the world attempting to get back to normalcy with COVID 19 after many have lost time, jobs and even lives. Through it all, this song gives the message of hope for the future and a word of encouragement for everyone to know that "Things are coming together".

Ayolabi Temitope Ezobi
Gods House International Centre
email us here

GHIC Music – Things Are Coming Together


Source: EIN Presswire

Natural Marketing Institute's Segmentation Reveals That 64% of FOOD ACTIVES Are Vaccinated

Natural Marketing Institute’s Health & Wellness Segmentations identify different vaccination behaviors

NEWTOWN SQUARE, PA, UNITED STATES, August 3, 2021 /EINPresswire.com/ — Natural Marketing Institute has developed a one-of-a-kind approach for measuring behaviors before and during the pandemic (COVID-19), and as a result, has trended, qualitative research among 7,000+ general population U.S. adults. The newest wave of this research, fielded in May 2021, focused on behaviors specifically related to the pandemic vaccine. These results were analyzed using the Institute’s Health & Wellness Consumer Segmentation, described below.

The Institute’s Health & Wellness Segmentation has five distinct, mutually exclusive segments across all Americans Adults aged 18+. These five segments include the following:

• WELL BEINGS – the most health proactive segment; they are early adopters and influencers who continually set the bar higher regarding their health
• FOOD ACTIVES – highly oriented toward more natural means of maintaining their health and take personal responsibility through weight maintenance, exercise, and choice of naturally nutritious foods
• MAGIC BULLETS – high condition managers searching for a “magic pill” to help manage their health, they have a high belief in the value of supplements and are the least healthy
• FENCE SITTERS – ‘health’ strivers who sometimes exhibit contradiction between their attitudes and their behaviors; highest likelihood of having children
• EAT, DRINK & BE MERRYS – least concerned about health and healthy eating and least knowledgeable about health-related benefits; they know they should eat healthier but often don’t

According to the most recent COVID-19 study by Natural Marketing Institute, about half of the U.S. general population (49%) has been fully vaccinated, which is comparable with CDC data at the same point in time. More importantly, the Institute found that 42% of FENCE SITTERS and 52% of EAT DRINK & BE MERRYS are not vaccinated and currently lag behind all the other segments. FOOD ACTIVES have the highest vaccination rate at 64% while WELL BEINGS, interestingly, have roughly the same rate as the general population.

In addition, the rate of those who have been fully vaccinated increases from generation to generation, with Young Millennials at 30%, steadily increasing to 65% for Boomers. Almost half of those with lower income (47%) have not had the vaccine; however, the percentage declines moving to the middle (37%) and then higher income (21%) brackets showing that income, in addition to age and health choices, is also a factor.

In this article, Natural Marketing Institute’s Health & Wellness Segmentations identify different vaccination behaviors, but these segments can be applied to thousands of categories providing strategic insights into various consumer behaviors and trends. For more information on the Institute’s proprietary segmentation tools, please contact Steve French, Senior Vice President, at 215-513-7300 or visit www.nmisolutions.com.

Natural Marketing Institute is an international strategic marketing consulting and market research firm specializing in building brands in the health & wellness, sustainability, and whole living marketplace. By utilizing a diverse mix of proprietary custom/primary methodologies and comprehensive syndicated data, the Institute provides its clients – across a multitude of industries – with insightful market analysis and strategic planning surrounding new opportunities, innovation, branding, communications, consumer target identification, sales strategy, and strategic business planning.

DeAnna Swinton
Natural Marketing Institute
+1 610-356-1800
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Insigniam’s co-founding partner, Shideh Sedgh Bina, has been named to the PharmaVOICE 100 Most Inspiring People

Insigniam’s co-founding partner, Shideh Sedgh Bina, has been named to the PharmaVOICE 100 Most Inspiring People

It has been my privilege for 32 years to work with executives and their workforces around the world to catalyze breakthrough, innovation and transformation in service of patients and consumers.”

— Shideh Sedgh Bina

PHILADELPHIA, PA, UNITED STATES, August 3, 2021 /EINPresswire.com/ — Insigniam, an international management consulting firm that specializes in breakthrough performance, innovation, transformation, and corporate culture, announced today that one of its co-founding partners, Shideh Sedgh Bina, has been named to the PharmaVOICE 100 Most Inspiring People: an annual list of the 100 most innovative, influential, and inspirational people in the life-sciences industry.

The PharmaVOICE 100 represents leaders from across the global life sciences industry. A panel of PharmaVOICE editors chose the winners based on their ability to inspire, motivate and influence corporate leadership, research and development, technology, creativity, marketing, and strategy.

Dissatisfied with the status quo of the consulting industry, Shideh Sedgh Bina co-founded Insigniam from the ground up in 1990, dedicated to developing an entirely new model for management consulting. She moved away from traditional advisory consulting, which does the work for their clients, and instead developed a unique and proprietary method that provokes the client to think newly about their business and their work, thereby taking very different actions and producing new and unprecedented results. To date, Insigniam clients include one-third of the Fortune 50, 80+ of the FT Global 500, over 110 companies of the Forbes Global 1000, and all 15 of the largest Pharmaceutical compani­­es in the world. “It has been my privilege for the last 32 years to work closely with executives and their workforces around the world to catalyze breakthroughs, innovation, and transformation in service of patients and consumers.”

Shideh has a longstanding commitment to the transformation of the healthcare industry and in 2021 was selected to serve as the Chair of the Board of Directors of the Healthcare Businesswomen's Associations. Additionally, in 2014, Shideh was selected as Woman of the Year by the Healthcare Businesswomen’s Association (HBA). The HBA is a global non-profit organization dedicated to gender equity in leadership for women in the healthcare industry.

She is also a Trustee of the Committee for Economic Development; a nonprofit, nonpartisan, business-led, public policy organization that delivers well-researched analysis and reasoned solutions on our nation’s most critical issues.

Natalie Rahn
Insigniam
+1 4842709010
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Hypolipidemics Market Growth Is Mainly Due To Changes In Diet And Lifestyle

Hypolipidemics Market Report 2021: COVID-19 Impact And Recovery To 2030

Hypolipidemics Global Market Report 2021: COVID-19 Impact And Recovery To 2030

The Business Research Company’s Hypolipidemics Global Market Report 2021: COVID-19 Impact And Recovery To 2030

LONDON, GREATER LONDON , UK, August 3, 2021 /EINPresswire.com/ — Shifts in diet and change in lifestyles of people is driving the growth of hypolipidemic drugs market. Increase in the consumption of unhealthy food, rising prevalence of smoking and drinking have led to an increase in the level of cholesterol intake by the people. According to a study by Global Burden of Disease (GBD) in 2019, high blood pressure contributed to almost 1.47 million deaths in India. The rising levels of cholesterol due to change in lifestyles of the people is rising demand for hypolipidemic drugs, as they aid in lowering cholesterol levels.

The global hypolipidemic market is expected to decline from $16.23 billion in 2020 to $15.94 billion in 2021 at a compound annual growth rate (CAGR) of -1.8%. The decline is mainly due to the companies' production being impacted negatively by COVID-19, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The hypolipidemic drugs market is expected to reach $18.41 billion in 2025 at a CAGR of 3.7%.

Read More On The Global Hypolipidemics Market Report:
https://www.thebusinessresearchcompany.com/report/hypolipidemics-global-market-report

Major players in the hypolipidemic agents market are ABBOTT LABORATORIES LIMITED, Apotex Fermentation Inc., Biocon Limited, Cadila Healthcare Limited and Chunghwa Chem Syn& Biotech Co., Ltd.

The regions covered in the hypolipidemic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The hypolipidemic drugs market consists of sales of hypolipidemic drugs and related services. This industry includes establishments that produce hypolipidemic drugs or agents that lower lipid and lipoproteins levels in the blood. These drugs can be used to prevent cardiovascular diseases and atherosclerosis in Hyperlipidemia patients. Some of the major hypolipidemic drugs include fibric acid derivatives, bile acid binding resins, nicotinamides, and cholesterol absorption inhibitors.

TBRC’s global hypolipidemics market report is segmented by product type into cholic acid regulator, HMG-CoA reductase inhibitors, adenylate cyclase inhibitors, nicotinic acid drugs, others and by application into hospital, clinics, pharmacy, cardiovasology.

Hypolipidemics Global Market Report 2021: COVID-19 Impact And Recovery To 2030 is one of a series of new reports from The Business Research Company that provides hypolipidemics market overview, forecast hypolipidemics market size and growth for the whole market, hypolipidemics market segments, and geographies, hypolipidemics market trends, hypolipidemics market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Hypolipidemics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2435&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Cardiovascular Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report-2020-30-covid-19-impact-and-recovery

Blood Glucose Meters Global Market Report 2021: COVID-19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Global Proteomics Market – By Component (Reagents, Instruments, Software), By Type (Protein Microarrays, Spectroscopy, X-ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/proteomics-market

Interested to know more about The Business Research Company?

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Global Veterinary Orthopedic Implants Market Trends, Strategies, And Opportunities In The Market 2021-2030

Veterinary Orthopedic Implants Market Report 2021: COVID-19 Growth And Change To 2030

Veterinary Orthopedic Implants Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Veterinary Orthopedic Implants Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, August 3, 2021 /EINPresswire.com/ — According to the new market research report ‘Veterinary Orthopedic Implants Global Market Report 2021: COVID-19 Growth And Change To 2030’ published by The Business Research Company, the global veterinary orthopedic implants market is expected to grow from $0.09 billion in 2020 to $0.1 billion in 2021 at a compound annual growth rate (CAGR) of 11.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $0.14 billion in 2025 at a CAGR of 9%. The increase in the incidence of obesity and arthritis in animals increases the demand for veterinary orthopedic implants market.

Request For A Sample For The Global Veterinary Orthopedic Implants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2830&type=smp

The veterinary orthopedic implants market consists of sales of veterinary orthopedic implants and related services. Veterinary orthopedic implants are used by veterinary surgeons for bone fixation surgeries, treating bone fractures in animals and are usually made of metals like pure commercial titanium (Ti) or titanium alloys, stainless steel, cobalt-chromium (Co-Cr) alloys. The orthopedic implants are also used as a support structure for healing fractures and reconstructive surgeries. Orthopedic implants include screws, plates, pins, and wires which are used in the surgeries performed on animals.

Trends In The Global Veterinary Orthopedic Implants Market
The companies in veterinary orthopaedic implants market are investing in 3D printing technique for creating veterinary orthopaedic implants. 3D printing in veterinary orthopaedics market is being used for creating printed bone models, surgical guides and titanium implants. The use of 3D printing reduces the surgical time, cost and removes the engineering complexities in orthopaedic procedures. Following the trend, many dogs with bone deformities have been treated by Langford Veterinary Services, a UK based provider of veterinary services, through its collaboration with CBM. The collaboration enabled CBM to create 3D printed models of animal implants using titanium Ti6AI4V EL material. The MRI or CT scans are sent from Langford Veterinary Services in Bristol to CBM who then produces 3D printed models using Arcam EBM Q10plus machine. CBM is a U.K based company focused on advanced research, product development, and batch manufacturing facility. Thus, the use of 3D printing is one of the latest trends in the veterinary orthopaedic implants market and will contribute to its growth.

Global Veterinary Orthopedic Implants Market Segments:
The global veterinary orthopedic implants market is further segmented based on type and geography.
By Product Type: Advanced Locking Plate System, Tibial Plateau Leveling Osteotomy Implants, Tibial Tuberosity Advancement Implants, Total Elbow Replacement, Total Hip Replacement, Total Knee Replacement, Trauma Fixations
By Animal: Dog, Cat, Others
By End-User: Veterinary Hospitals, Veterinary Clinics, Veterinary Surgical Centers
By Geography: The global veterinary orthopedic implants market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Veterinary Orthopedic Implants Market At:
https://www.thebusinessresearchcompany.com/report/veterinary-orthopedic-implants-market-global-report

Veterinary Orthopedic Implants Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides veterinary orthopedic implants market overviews, analyzes and forecasts market size and growth for the global veterinary orthopedic implants market, veterinary orthopedic implants market share, veterinary orthopedic implants market players, veterinary orthopedic implants market segments and geographies, veterinary orthopedic implants market’s leading competitors’ revenues, profiles and market shares. The veterinary orthopedic implants market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read Veterinary Orthopedic Implants Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Veterinary Orthopedic Implants Market Organizations Covered: KYON Pharma Inc., Veterinary Orthopedic Implants Inc., BioMedtrix, LLC, IMEX Veterinary Inc., Orthomed (UK) Ltd, Securos Surgical, B.Braun Vet Care, Bluesao, DePuy Synthes Vet

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Veterinary Orthopedic Implants Global Market Report 2021:

Veterinary Market – By Type Of Pharamaceutical (Veterinary Parasiticides, Veterinary Vaccines, Veterinary Antibiotics, and Other Veterinary Pharmaceuticals), By Animal Type (Livestock and Companion Animal), By Route Of Administration (Oral and Others), By End Use Channel (Veterinary Hospitals, Pharmacies and Drug stores and Veterinary Clinics), By Type Of Antibiotic (Tetracyclines, Penicillin, Macrolides, Sulphanomides, Aminoglycosides, and Others), By Type Of Vaccine (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market

Orthopedic Biomaterials Market – By Material Type (Ceramics & Bioactive Glasses, Calcium Phosphate Cements, Polymers, Metal, Composites), By Application (Joint Replacement/Reconstruction, Bio-Resorbable Tissue Fixation, Other Orthopedic Implants, Other Orthopedic Biomaterials), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/orthopedic-biomaterials-market

Orthopedic Prosthetics Global Market Report 2021: COVID-19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/orthopedic-prosthetics-global-market-report

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire